TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding July 2, 1993
TCL Archive In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule November 5, 1976
TCL Archive Funding Opportunities: NIH seeks “visionary thinkers” for awards of $2.5 million over five years. NCI RFA available. January 23, 2004
